The oral contraceptive market grew greatly last year. Sales of the fourth-generation contraceptive Bayer Korea’s Yaz increased greatly, and the return of the third-generation Dong-A Pharmaceutical’s Mybora and the release of GC Pharm’s Dearmesoon had also contributed to market expansion.

According to the market research institution IQVIA on the 8th, the oral contraceptive market size increased 19.6% YoY to record ₩38.4 billion last year. The oral contraceptive market grew from ₩32.8 billion in 2017 to ₩34.9 billion in 2019. In 2020, the market size reduced slightly to ₩32.1 billion but then made a rebound last year.